Clinical Trials Logo

Neoplasms clinical trials

View clinical trials related to Neoplasms.

Filter by:

NCT ID: NCT04954456 Recruiting - Clinical trials for Advanced Malignant Tumor

A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies

Start date: June 2, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, open label, non-randomised, dose-escalation single agent study with expansion cohorts for dose confirmation/safety and preliminary efficacy of QLS31901 in advanced or metastatic malignancies

NCT ID: NCT04952974 Recruiting - Clinical trials for Chronic Lymphocytic Leukemia

B-cell Chronic Lymphoid Malignancies Markers

MALYZOMA-II
Start date: June 14, 2021
Phase:
Study type: Observational

Lymphoid chronic B-cell malignancies are frequent pathologies that affect adults, with a very variable prognosis and treatment (some of them can remain untreated). The diagnosis of these malignancies relies on the study of the morphology of tumoral cells and the expression by these cells of several markers, mainly via a technical approach called flow cytometry. Because the markers currently used remain imperfect, additional ones are needed for an accurate diagnosis that affect both prognosis and treatment. In addition, because numerous markers are used at the diagnosis, there is a need of tools that synthetize the multi-dimensional structure of the data obtained. The primary purpose of this study is to detect new markers that can be of help for the diagnosis of Marginal Zone Lymphoma and other B-cell chronic lymphoid malignancies. The secondary purpose of this study is to obtain a statistical algorithm that allow a good prediction of the different sub-types of chronic B-cell malignancies mainly using the results of flow cytometry.

NCT ID: NCT04952116 Recruiting - Periocular Tumors Clinical Trials

Aesthetic and Functional Outcomes of Eyelid Reconstruction After Excision of Periocular Tumors

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

- To determine the aesthetic and functional outcomes of different techniques used in eyelid reconstruction following periocular defects. - To determine the complications of eyelid reconstruction and how to prevent them

NCT ID: NCT04949282 Recruiting - Neoplasms Clinical Trials

Spanish Series of Patients Treated With the Radionuclide Lutetium177

SEPTRALU
Start date: May 10, 2021
Phase:
Study type: Observational

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.

NCT ID: NCT04948762 Recruiting - Clinical trials for Locally Advanced Rectal Cancer

A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery

Start date: August 1, 2021
Phase:
Study type: Observational

Minimally-invasive surgery (MIS) techniques have revolutionised the approach to rectal cancer surgery. With increasing experience, surgeons have began to utilise these platforms increasingly in the context of pelvic exenteration (PE). This observational retrospective review plans to assess the volume of PE being performed on a global basis and to assess the comparative outcomes associated with each technique in order to assess the optimal approach to radical pelvic surgery.

NCT ID: NCT04947033 Recruiting - Clinical trials for Advanced Solid Tumor

A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors

Start date: December 31, 2023
Phase: Phase 1
Study type: Interventional

A phase I clinical study evaluating TJ210001 in the treatment of subjects with advanced solid tumors

NCT ID: NCT04942717 Recruiting - Solid Tumor Clinical Trials

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Start date: June 18, 2021
Phase:
Study type: Observational

The purpose of this study is to translate and tailor for Latinx participants a program called Communicating with Oncology Nurses about Values from the Outset (CONVO). In CONVO, routine cancer care for each participant includes a discussion between the nurse and participant about the participant's health-related values.

NCT ID: NCT04941430 Recruiting - Metastatic Melanoma Clinical Trials

7T MRI Scan for the Early Detection of Melanoma Brain Metastases

Start date: June 25, 2021
Phase: N/A
Study type: Interventional

This clinical trial studies the use of 7-Tesla (7T) magnetic resonance imaging (MRI) in detecting melanoma that has spread to the brain (melanoma brain metastases). The standard MRI brain imaging is done on 3T or similar MRI machine, but the 7T MRI machine has a larger magnet which has been shown to have superior resolution of the brain and of non-cancerous brain lesions. Diagnostic procedures such as 7T MRI may help find and diagnose melanoma brain metastases earlier than standard 3T MRI.

NCT ID: NCT04941339 Recruiting - Clinical trials for Advanced Solid Tumor

A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors

Start date: November 21, 2018
Phase: Phase 1
Study type: Interventional

The objective of this study is to assess the safety, efficacy, pharmacokinetics, and immunogenicity of MRG002 in patients with HER2-positive advanced solid tumors.

NCT ID: NCT04940936 Recruiting - Radiation Toxicity Clinical Trials

Shared Decision Making on Radiation Dose for Lung Malignancies

Start date: November 12, 2021
Phase: N/A
Study type: Interventional

A Patient Decision Aid (PtDA) is developed during a workshop in close collaboration with selected patients. The PtDA is subsequently used in the consultation between patient and physician to facilitate their shared decision on the dose of stereotactic body radiation therapy (SBRT) for lung tumors located less than 1 cm from the thoracic wall. Hypothesis: The use of a PtDA will increase the extent of Shared Decision Making (SDM) during the consultation and result in patients being more directly involved in the planning of their treatment.